Literature DB >> 9170099

The effects of interferon-gamma on the central nervous system.

B Popko1, J G Corbin, K D Baerwald, J Dupree, A M Garcia.   

Abstract

Interferon-gamma (IFN-gamma) is a pleotropic cytokine released by T-lymphocytes and natural killer cells. Normally, these cells do not traverse the blood-brain barrier at appreciable levels and, as such, IFN-gamma is generally undetectable within the central nervous system (CNS). Nevertheless, in response to CNS infections, as well as during certain disorders in which the CNS is affected, T-cell traffic across the blood-brain barrier increases considerably, thereby exposing neuronal and glial cells to the potent effects of IFN-gamma. A larger portion of this article is devoted to the substantial circumstantial and experimental evidence that suggests that IFN-gamma plays an important role in the pathogenesis of the demyelinating disorder multiple sclerosis (MS) and its animal model experimental allergic encephalomyelitis (EAE). Moreover, the biochemical and physiological effects of IFN-gamma are discussed in the context of the potential consequences of such activities on the developing and mature nervous systems.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9170099      PMCID: PMC7091409          DOI: 10.1007/BF02740619

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  140 in total

1.  Viral persistence in neurons explained by lack of major histocompatibility class I expression.

Authors:  E Joly; L Mucke; M B Oldstone
Journal:  Science       Date:  1991-09-13       Impact factor: 47.728

Review 2.  T helper cell differentiation in immune response.

Authors:  S L Reiner; R A Seder
Journal:  Curr Opin Immunol       Date:  1995-06       Impact factor: 7.486

3.  Major histocompatibility complex class I expression in oligodendrocytes induces hypomyelination in transgenic mice.

Authors:  C Power; P A Kong; B D Trapp
Journal:  J Neurosci Res       Date:  1996-04-15       Impact factor: 4.164

Review 4.  Acquisition of lymphokine-producing phenotype by CD4+ T cells.

Authors:  R A Seder; W E Paul
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

5.  Expression of major histocompatibility complex on human medulloblastoma cells with neuronal differentiation.

Authors:  K Tamura; K Shimizu; M Yamada; Y Okamoto; Y Matsui; K C Park; E Mabuchi; S Moriuchi; H Mogami
Journal:  Cancer Res       Date:  1989-10-01       Impact factor: 12.701

6.  The effect of cytokines on the expression and function of Fc receptors for IgG on human myeloid cells.

Authors:  D V Erbe; J E Collins; L Shen; R F Graziano; M W Fanger
Journal:  Mol Immunol       Date:  1990-01       Impact factor: 4.407

7.  Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development.

Authors:  J G Corbin; D Kelly; E M Rath; K D Baerwald; K Suzuki; B Popko
Journal:  Mol Cell Neurosci       Date:  1996-05       Impact factor: 4.314

8.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

Authors:  D K Dalton; S Pitts-Meek; S Keshav; I S Figari; A Bradley; T A Stewart
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

Review 9.  The molecular cell biology of interferon-gamma and its receptor.

Authors:  M A Farrar; R D Schreiber
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

10.  The induction of intercellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-gamma, tumor necrosis factor alpha, lymphotoxin, and interleukin-1: relevance to intracerebral antigen presentation.

Authors:  E M Frohman; T C Frohman; M L Dustin; B Vayuvegula; B Choi; A Gupta; S van den Noort; S Gupta
Journal:  J Neuroimmunol       Date:  1989-07       Impact factor: 3.478

View more
  53 in total

Review 1.  Advanced transgenic and gene-targeting approaches.

Authors:  X Gao; A Kemper; B Popko
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

2.  Interferon-γ inhibits central nervous system myelination through both STAT1-dependent and STAT1-independent pathways.

Authors:  Wensheng Lin; Yifeng Lin
Journal:  J Neurosci Res       Date:  2010-09       Impact factor: 4.164

3.  Toxoplasma gondii prevents neuron degeneration by interferon-gamma-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-beta1 production by infected microglia.

Authors:  Claudia Rozenfeld; Rodrigo Martinez; Sérgio Seabra; Celso Sant'anna; J Gabriel R Gonçalves; Marcelo Bozza; Vivaldo Moura-Neto; Wanderley De Souza
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

4.  The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage.

Authors:  Wensheng Lin; Samantha L Bailey; Hanson Ho; Heather P Harding; David Ron; Stephen D Miller; Brian Popko
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

Review 5.  Endoplasmic reticulum stress and the unfolded protein response in disorders of myelinating glia.

Authors:  Benjamin L L Clayton; Brian Popko
Journal:  Brain Res       Date:  2016-04-04       Impact factor: 3.252

6.  Deleterious role of IFNgamma in a toxic model of central nervous system demyelination.

Authors:  Paula Maña; David Liñares; Sue Fordham; Maria Staykova; David Willenborg
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

7.  Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gamma.

Authors:  Wensheng Lin; Phillip E Kunkler; Heather P Harding; David Ron; Richard P Kraig; Brian Popko
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

Review 8.  Transgenic models for cytokine-induced neurological disease.

Authors:  Iain L Campbell; Markus J Hofer; Axel Pagenstecher
Journal:  Biochim Biophys Acta       Date:  2009-10-14

9.  Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis.

Authors:  Kaiyong Yang; Jose L Vega; Muhamed Hadzipasic; Jean Pierre Schatzmann Peron; Bing Zhu; Yijun Carrier; Sharmila Masli; Luiz Vicente Rizzo; Howard L Weiner
Journal:  J Autoimmun       Date:  2009-02-01       Impact factor: 7.094

Review 10.  Oligodendroglial response to the immune cytokine interferon gamma.

Authors:  B Popko; K D Baerwald
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.